Profile data is unavailable for this security.
About the company
StemRIM Inc. is a Japan-based company mainly engaged in the regenerative medicine business. The Company is engaged in the development and research of medicines based on new action mechanism to promote functional regeneration and healing of biological tissue damaged and lost function due to injury or illness. The Company’s main product is stem cell regeneration-inducing medicine. The stem cell regeneration-inducing medicine is a medicine which can obtain the same therapeutic effect as regenerative medicine only by administering the medicine without using living cells and tissues.
- Revenue in JPY (TTM)0.00
- Net income in JPY-2.13bn
- Incorporated2006
- Employees44.00
- LocationStemRIM Inc3F, Saito Bio-Incubator, 7-7-15, SaitoIBARAKI-SHI 567-0085JapanJPN
- Phone+81 726487152
- Websitehttps://stemrim.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RaQualia Pharma Inc | 2.18bn | -253.40m | 13.81bn | 67.00 | -- | 2.30 | -- | 6.33 | -11.72 | -11.72 | 100.79 | 277.21 | 0.247 | 2.76 | 3.03 | 32,526,720.00 | -2.87 | 2.13 | -3.18 | 2.26 | 88.70 | 88.49 | -11.63 | 5.32 | 3.53 | -- | 0.4031 | 0.00 | -34.85 | 20.62 | -144.74 | -- | 0.0967 | -- |
Symbio Pharmaceuticals Ltd | 4.64bn | -2.74bn | 14.23bn | 109.00 | -- | 1.98 | -- | 3.07 | -66.88 | -66.88 | 113.80 | 156.38 | 0.5439 | 2.76 | 5.14 | 42,594,130.00 | -32.15 | -19.18 | -35.33 | -23.62 | 78.38 | 65.84 | -59.12 | -24.32 | 10.43 | -- | 0.00 | -- | -44.15 | 7.82 | -266.45 | -- | 42.39 | -- |
Stella Pharma Corp | 269.49m | -763.75m | 14.45bn | 44.00 | -- | 5.70 | -- | 53.63 | -24.63 | -24.63 | 8.70 | 76.12 | 0.0661 | 0.0508 | 3.98 | 6,124,796.00 | -18.74 | -22.50 | -21.00 | -24.83 | 80.63 | -- | -283.40 | -488.65 | 5.52 | -1,319.97 | 0.2819 | -- | 17.65 | -- | 1.94 | -- | -5.87 | -- |
Ohki Healthcare Holdings Co Ltd | 334.66bn | 2.21bn | 14.55bn | 632.00 | 6.44 | 0.5067 | 5.81 | 0.0435 | 160.45 | 160.45 | 24,293.96 | 2,040.70 | 2.56 | 13.33 | 4.80 | 529,526,900.00 | 1.63 | 1.85 | 7.07 | 8.42 | 5.14 | 6.16 | 0.6356 | 0.7178 | 0.8922 | -- | 0.1996 | 13.92 | 9.92 | 5.30 | 1.28 | 1.51 | -5.34 | 5.92 |
Fuso Pharmaceutical Industries Ltd | 55.41bn | 1.38bn | 22.20bn | 1.31k | 14.70 | 0.5475 | 6.20 | 0.4007 | 159.76 | 159.76 | 6,434.77 | 4,290.49 | 0.7474 | 3.12 | 2.43 | 42,392,500.00 | 1.86 | 1.91 | 3.06 | 3.09 | 24.98 | 26.92 | 2.49 | 2.69 | 1.04 | 54.56 | 0.2576 | 41.10 | 8.61 | 3.76 | -14.21 | 9.02 | 9.13 | -2.64 |
Astena Holdings Co Ltd | 52.63bn | 1.62bn | 23.32bn | 1.40k | 13.89 | 0.7876 | 6.06 | 0.4431 | 40.98 | 40.98 | 1,332.61 | 722.46 | 0.8127 | 3.31 | 2.76 | 37,482,540.00 | 2.49 | 2.49 | 4.44 | 4.44 | 32.27 | 25.33 | 3.06 | 2.32 | 0.8713 | -- | 0.3517 | 44.92 | 4.73 | -2.85 | 100.61 | -3.85 | 38.54 | 11.38 |
TAIKO PHARMACEUTICAL CO LTD | 6.33bn | -2.90bn | 23.50bn | 208.00 | -- | 3.13 | -- | 3.71 | -58.49 | -58.49 | 129.20 | 148.04 | 0.462 | 2.04 | 3.44 | 30,432,690.00 | -21.14 | -- | -26.00 | -- | 44.27 | -- | -45.75 | -- | 2.92 | -- | 0.2811 | -- | 21.43 | -- | 26.23 | -- | -- | -- |
StemRIM Inc | 0.00 | -2.13bn | 27.19bn | 44.00 | -- | 2.90 | -- | -- | -34.87 | -34.87 | 0.00 | 152.36 | 0.00 | -- | -- | 0.00 | -20.52 | -6.71 | -20.87 | -6.83 | -- | -- | -- | -45.80 | 99.90 | -8,295.36 | 0.00 | -- | 10,128.06 | 63.68 | 108.64 | -- | -- | -- |
CellSeed Inc | 193.68m | -892.21m | 33.58bn | 35.00 | -- | 15.00 | -- | 173.38 | -29.71 | -29.71 | 6.47 | 64.75 | 0.088 | 1.63 | 7.62 | 5,533,600.00 | -40.53 | -49.69 | -43.83 | -54.55 | 56.58 | 63.66 | -460.67 | -428.62 | 19.14 | -- | 0.0669 | -- | 50.39 | -28.62 | -11.43 | -- | 80.73 | -- |
Daito Pharmaceutical Co Ltd | 46.90bn | 3.30bn | 33.74bn | 1.01k | 10.22 | 0.6312 | 6.93 | 0.7194 | 210.18 | 210.18 | 2,988.73 | 3,404.72 | 0.6326 | 1.89 | 2.96 | -- | 4.29 | 6.27 | 5.58 | 8.24 | 20.98 | 22.65 | 6.78 | 8.47 | 1.11 | -- | 0.143 | 18.48 | 3.98 | 2.66 | -8.47 | -1.27 | 11.37 | 11.67 |
Fuji Pharma Co Ltd | 43.05bn | 5.92bn | 38.12bn | 1.62k | 6.32 | 0.8497 | 4.14 | 0.8855 | 243.57 | 243.57 | 1,771.38 | 1,812.38 | 0.5071 | 1.34 | 3.21 | 26,558,910.00 | 6.97 | 4.10 | 10.56 | 5.58 | 39.78 | 42.41 | 13.75 | 7.55 | 0.5895 | -- | 0.3826 | 31.17 | 15.42 | 1.52 | 27.41 | 0.3709 | 19.04 | 5.73 |
Data as of Jul 17 2024. Currency figures normalised to StemRIM Inc's reporting currency: Japanese Yen JPY
2.58%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Schroder Investment Management (Japan) Ltd.as of 31 Mar 2024 | 628.50k | 1.02% |
Schroder Investment Management Ltd.as of 31 Dec 2023 | 342.10k | 0.56% |
Daiwa Asset Management Co. Ltd.as of 31 Dec 2023 | 279.40k | 0.45% |
Simplex Asset Management Co., Ltd.as of 04 Jul 2024 | 167.20k | 0.27% |
Mitsubishi UFJ Asset Management Co., Ltd.as of 31 Dec 2023 | 109.40k | 0.18% |
Meiji Yasuda Asset Management Co. Ltd.as of 29 Nov 2022 | 35.00k | 0.06% |
SSgA Funds Management, Inc.as of 03 Jul 2024 | 18.60k | 0.03% |
LGT Capital Partners AG (Investment Management)as of 30 Nov 2023 | 2.70k | 0.00% |
Amundi Japan Ltd.as of 12 Sep 2022 | 2.00k | 0.00% |
Connor, Clark & Lunn Investment Management Ltd.as of 31 Dec 2023 | 1.50k | 0.00% |
More ▼
Data from 31 Mar 2024 - 11 Jul 2024Source: FactSet Research Systems Inc.